Gressner AM - Search Results

1

Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.

Yagmur E, Trautwein C, Gressner AM, Tacke F. Yagmur E, et al. Among authors: gressner am. Am J Gastroenterol. 2006 Jun;101(6):1244-52. doi: 10.1111/j.1572-0241.2006.00543.x. Am J Gastroenterol. 2006. PMID: 16771945

2

Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.

Yagmur E, Tacke F, Weiss C, Lahme B, Manns MP, Kiefer P, Trautwein C, Gressner AM. Yagmur E, et al. Among authors: gressner am. Clin Biochem. 2006 Jan;39(1):39-45. doi: 10.1016/j.clinbiochem.2005.07.016. Clin Biochem. 2006. PMID: 16321365

3

Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Yagmur E, et al. Among authors: gressner am. Diabetes Care. 2007 May;30(5):1168-72. doi: 10.2337/dc06-2323. Epub 2007 Mar 2. Diabetes Care. 2007. PMID: 17337499

4

Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.

Yagmur E, Rizk M, Stanzel S, Hellerbrand C, Lammert F, Trautwein C, Wasmuth HE, Gressner AM. Yagmur E, et al. Among authors: gressner am. Eur J Gastroenterol Hepatol. 2007 Sep;19(9):755-61. doi: 10.1097/MEG.0b013e3282202bea. Eur J Gastroenterol Hepatol. 2007. PMID: 17700260

5

Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation.

Yagmur E, Trautwein C, Leers MP, Gressner AM, Tacke F. Yagmur E, et al. Among authors: gressner am. Clin Biochem. 2007 Jun;40(9-10):651-5. doi: 10.1016/j.clinbiochem.2006.12.010. Epub 2007 Jan 17. Clin Biochem. 2007. PMID: 17306787

6

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Wasmuth HE, et al. Among authors: gressner am. J Hepatol. 2005 Feb;42(2):195-201. doi: 10.1016/j.jhep.2004.10.019. J Hepatol. 2005. PMID: 15664244

7

Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis.

Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S. Gressner AM, et al. Among authors: gressner o. Clin Chem. 2006 Sep;52(9):1815-7. doi: 10.1373/clinchem.2006.070466. Epub 2006 Jul 20. Clin Chem. 2006. PMID: 16858074

8

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R. Kovalenko E, et al. Among authors: gressner oa, gressner am. J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20. J Viral Hepat. 2009. PMID: 19243500

9

Saliva collection method affects predictability of serum cortisol.

Poll EM, Kreitschmann-Andermahr I, Langejuergen Y, Stanzel S, Gilsbach JM, Gressner A, Yagmur E. Poll EM, et al. Clin Chim Acta. 2007 Jul;382(1-2):15-9. doi: 10.1016/j.cca.2007.03.009. Epub 2007 Mar 19. Clin Chim Acta. 2007. PMID: 17449021 Clinical Trial.

10

Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay.

Yagmur E, Driesch R, Gressner AM, Kiefer P. Yagmur E, et al. Among authors: gressner am. Clin Chem Lab Med. 2006;44(4):420-2. doi: 10.1515/CCLM.2006.083. Clin Chem Lab Med. 2006. PMID: 16599835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page